Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
2(33%)
Results Posted
33%(1 trials)

Phase Distribution

Ph phase_4
1
17%
Ph phase_3
1
17%
Ph not_applicable
4
67%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
4(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Completed(3)
Other(1)

Detailed Status

Completed3
Recruiting1
Active, not recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (16.7%)
Phase 41 (16.7%)
N/A4 (66.7%)

Trials by Status

recruiting117%
active_not_recruiting117%
completed350%
unknown117%

Recent Activity

2 active trials
Showing 5 of 6
active_not_recruitingnot_applicable

Allogeneic Adipose Tissue Extract in Wound Treatment and Scar Maturation

NCT07372404
recruitingphase_3

Phase 3 - Evaluation of Veregen® 10% Ointment as New Herbal Topical Treatment for Actinic Keratosis

NCT07137819
completednot_applicable

EmoLED Medical Device Treatment of Second and Third Stage Pressure Ulcers

NCT05130814
completednot_applicable

Effectiveness and Safety of Nailner Brush 2in1 in Onychomycosis

NCT05560841
unknownnot_applicable

Enhanced Transcutaneous Delivery of Betamethasone for the Treatment of Vitiligo

NCT05233735
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07372404Not Applicable

Allogeneic Adipose Tissue Extract in Wound Treatment and Scar Maturation

Active Not Recruiting
NCT07137819Phase 3

Phase 3 - Evaluation of Veregen® 10% Ointment as New Herbal Topical Treatment for Actinic Keratosis

Recruiting
NCT05130814Not Applicable

EmoLED Medical Device Treatment of Second and Third Stage Pressure Ulcers

Completed
NCT05560841Not Applicable

Effectiveness and Safety of Nailner Brush 2in1 in Onychomycosis

Completed
NCT05233735Not Applicable

Enhanced Transcutaneous Delivery of Betamethasone for the Treatment of Vitiligo

Unknown
NCT00940862Phase 4

Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Severe Plaque Psoriasis

Completed

All 6 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
6